Free scoping read. A written assessment of your manuscript in two business days, at no cost.

Start one

ConferenceMedicine and clinical research · Barcelona, Spain

EHA2027 Congress

EHA2027, the European Hematology Association’s congress in Barcelona from 10 to 13 June 2027, is Europe’s main haematology meeting and invites abstracts on clinical and laboratory research in blood disorders and haematologic malignancies. This guide covers topic areas consistent with that scope, checks before submitting an abstract, what reviewers typically value and how to prepare a submission before the 1 March 2027 abstract deadline.

Pubrica InsightsEditorial team, reviewed by a subject specialist
Next deadline
1 March 2027
Last checked
10 November 2026
Organiser
European Hematology Association (EHA)
Sources
1
Submit an abstract

Key dates

Abstract deadline
1 March 2027
Full paper deadline
Abstracts only, or not stated
Conference dates
10 June 2027 – 13 June 2027
Details last checked
10 November 2026
Submit an abstract

About the conference

Conference
EHA2027 Congress
Organiser
European Hematology Association (EHA)
Venue
Barcelona, Spain
Scope
Europe's main haematology congress, inviting abstracts on clinical and laboratory research in blood disorders and haematologic malignancies.
Submission types
Abstracts; confirm formats and word limits on the official page

Topics consistent with the programme

  • Clinical trials and real-world outcomes in haematologic malignancies such as leukaemia and lymphoma
  • Laboratory studies of disease mechanisms in myeloid and lymphoid neoplasms
  • Diagnosis and management of non-malignant blood disorders, including anaemias and haemoglobinopathies
  • Thrombosis, haemostasis and bleeding disorders in clinical and translational research
  • Cellular and immune therapies, including stem cell transplantation and CAR-T approaches
  • Biomarkers, genomics and measurable residual disease in haematology

Based on the published scope; the official page sets out the full themes and requirements.

Is your work a fit? Check before you submit

  1. Confirm the work reports clinical or laboratory research on blood disorders or haematologic malignancies.
  2. Check that the results are original and meet the congress rules on prior presentation and publication.
  3. Choose the most suitable abstract category and confirm the categories listed on the official EHA2027 page.
  4. Ensure the abstract states its aim, methods, key results and conclusion within the official format.
  5. Submit a complete, co-author-approved abstract before 1 March 2027.

Why This Conference Matters

Haematology is changing quickly as molecular diagnostics, targeted agents and cellular therapies move from trials into routine care, while many patients with non-malignant blood disorders still face limited options. A large European congress brings clinicians, laboratory scientists and trialists together to compare evidence across these areas. Presenting at EHA2027 allows researchers to share findings with an international haematology audience, receive feedback from specialists working on similar questions and build collaborations for further clinical and translational work.

Who Should Submit

Academic backgrounds

  • Clinical haematology
  • Haemato-oncology
  • Laboratory and molecular haematology
  • Transfusion medicine
  • Paediatric haematology

Institutions and sectors

  • University hospitals and cancer centres
  • Academic research institutes
  • Pharmaceutical and biotechnology companies
  • Clinical trial groups and cooperative networks

What Reviewers Typically Value

  1. Clinical data that clarify the effectiveness or safety of a treatment in a defined patient group.
  2. Laboratory findings that explain a disease mechanism and suggest a testable clinical implication.
  3. Real-world or registry analyses that complement evidence from controlled trials.
  4. Clearly reported methods and results that allow reviewers to judge the strength of the conclusions.

Ideas You Could Develop

Real-world outcomes of a targeted therapyA registry-based analysis of response, toxicity and survival in patients receiving a targeted agent outside clinical trials.
Residual disease and relapse riskA study relating measurable residual disease results to relapse in a defined cohort with a haematologic malignancy.
Quality of care in haemoglobinopathiesAn audit of diagnosis, treatment and follow-up for patients with sickle cell disease or thalassaemia in a regional service.

Your Plan to the Deadline

A suggested schedule working back from 1 March 2027. Adjust it to the stage your work has reached.

  1. By 18 Jan 2027

    Open the official call for abstracts; confirm the tracks, word limit, format and author rules.

  2. By 1 Feb 2027

    Agree the key result, the authors and the presenting author.

  3. By 15 Feb 2027

    Draft the structured abstract to the word limit, with results stated as numbers.

  4. By 22 Feb 2027

    Circulate to co-authors and an independent reader; revise.

  5. By 27 Feb 2027

    Final checks: title, author affiliations, conflicts of interest and track selection.

  6. By 1 Mar 2027

    Submit through the official abstract system before the deadline.

What you gain

  • Feedback from peers working on the same questions.
  • A citable abstract or proceedings paper.
  • Contacts for collaboration, employment and future funding.
  • A step towards a full journal article.

What happens after you submit

  1. Acknowledgement: the abstract system confirms receipt; keep the submission number.
  2. Review: the scientific committee scores abstracts against the track criteria.
  3. Decision: accepted abstracts are assigned to an oral, poster or e-poster session.
  4. Registration: presenting authors usually must register by a stated date.
  5. Publication: accepted abstracts or papers may appear in the conference proceedings or journal supplement.

What the Organisers Are Looking For

EHA2027 is looking for abstracts reporting clinical and laboratory research on blood disorders and haematologic malignancies, from basic mechanisms through to trials and real-world outcomes. Strong submissions typically present original data, a clear question and conclusions that follow from the results. Abstract categories, formatting rules and presentation formats should be confirmed on the official EHA2027 details and deadlines page.

Read the official pageThis guide summarises the opportunity. Confirm deadlines, eligibility and requirements on the official page before you plan your work, and record the date you checked it.Open the official page

Expert help

How Pubrica Can Help

Pubrica’s subject specialists can help you prepare the abstract, full paper, poster or slides, planned back from the deadline. You remain the author of your work.

Abstract writingA structured abstract written to the conference’s word limit and format. Full paper writingFull conference papers written to the proceedings template. Poster preparationScientific posters designed to the conference’s size and layout rules. Presentation slidesOral presentation slides prepared for the allotted time. Editing and proofreadingSubject-specialist editing of abstracts and papers before submission. BiostatisticsStatistical analysis and review of results.
Go to the official page

FAQs

Questions Researchers Ask

The next published deadline is 1 March 2027. Dates can change, so confirm them on the official page before you plan your work.

Interim or early results may be considered if they contain meaningful data, but rules on trials in progress and encore abstracts vary. Check the EHA2027 abstract guidelines on the official details and deadlines page before submitting.

The official page lists abstract submission; check it for any full paper or proceedings option.

Yes. Pubrica’s specialists can review, write, edit and format your abstract, paper, poster or slides. You remain the author and the person responsible for the submission.

Sources

  1. European Hematology Association (EHA). (2026). EHA2027 Congress. Retrieved 10 November 2026, from https://ehaweb.org/connect-network/eha2027-congress/eha2027-details-and-deadlines

How to cite this page

Pubrica Insights. (2026). EHA2027 Congress. Pubrica. https://pubrica.com/insights/calls-and-conferences/eha2027-congress/

  • EHA2027
  • Haematology
  • Haematologic malignancies
  • Blood disorders
  • Barcelona

Other Open Conferences

Closes 16 November 202636th Annual Meeting of the Asian Pacific Association for the Study of the Liver (APASL 2027)Australia Closes 18 November 2026ESCMID Global 2027Sweden Closes 19 November 2026ESC Preventive Cardiology 2027Portugal

All calls, conferences and fundingAbstract writing

EHA2027Next deadline 1 March 2027

Official page
Get a free quote

Regulations

Check your project against this rule

  1. 1Your work
  2. 2Your details
  3. 3Send
What do you need?

Material you send is held under signed confidentiality, with access limited to the assigned team and encrypted transfer. It is not used to train anything and is not passed to third-party tools. Ask for the agreement before you send anything you would rather cover first.